Monogenic Obesity

Rare monogenic diseases that cause obesity

Actor portrayals
Boy sitting under a table and eating at a birthday party. Actor portrayal.

Rare monogenic diseases that cause obesity are likely underdiagnosed

These diseases are characterized by 2 key features related to weight: hyperphagia and early-onset obesity.1

People affected by rare monogenic obesity may present with additional clinical characteristics, including neurological, growth, and endocrine abnormalities, as well as a family history of weight differences between family members.2,3

What are the unique signs and symptoms associated with monogenic obesity?

POMC deficiency1–5

Signs and symptoms of
proopiomelanocortin (POMC) deficiency
may include:

  • Early-onset, severe obesity
  • Hyperphagia
  • Endocrine abnormalities

PCSK1 deficiency1–4,6–8

Signs and symptoms of proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency may include:

  • Early-onset, severe obesity
  • Hyperphagia
  • Postnatal diarrhea within the first weeks of life
  • Hyperinsulinemia
  • Hypoglycemia
  • Metabolic acidosis

LEPR deficiency1,2,9

Signs and symptoms of leptin receptor (LEPR) deficiency may include:

  • Early-onset, severe obesity
  • Hyperphagia
  • Hypogonadotropic hypogonadism

Additional diseases2,3,10,11

There are other diseases with early-onset obesity and hyperphagia due to melanocortin-4 receptor (MC4R) pathway impairment.

These rare monogenic diseases also have unique signs and symptoms:

  • SH2B1 deficiency: Insulin resistance
  • SRC1 deficiency: Hyperleptinemia and insulin resistance
Uncovering Rare Obesity icon

Genetic testing through the Uncovering Rare Obesity® program is available for eligible patients. For more information about the genetic testing program, visit

UncoveringRareObesity.com

Understanding the role of the hypothalamic MC4R pathway in obesity and hunger

The MC4R pathway regulates hunger, satiety, and energy balance.1,15,16
The MC4R pathway plays a key role in regulating hunger, which involves neural activation within the hypothalamic region in response to leptin release. Leptin binding to the LEPR triggers a signaling cascade that includes the secretion of alpha-melanocyte-stimulating hormone from the POMC neuron that binds to the MC4 receptor. This activation of the MC4R pathway regulates hunger, satiety, and energy expenditure, so weight and energy remain in balance.
Genetic dysfunction in the MC4R pathway can impair MC4R pathway signaling,
ultimately leading to accelerated and sustained weight gain.1,2,16
A variant in one or more genes can impair the MC4R pathway in the hypothalamus, leading to disruption of satiety signaling. Alpha-melanocyte-stimulating hormone production is impaired or deficient, which prevents activation of the MC4 receptor and impairment of the MC4R pathway. This leads to decreased satiety signaling, hyperphagia, and reduced energy expenditure, all of which can lead to a different obesity.

POMC=Proopiomelanocortin

Get connected. Find resources and get more information.

References
  1. Eneli I, Xu J, Webster M, et al. Tracing the effect of the melanocortin-4 receptor pathway in obesity: study design and methodology of the TEMPO registry. Appl Clin Genet. 2019 Jun 5;12:87-93. doi:10.2147/TACG.S199092
  2. Huvenne H, Dubern B, Clément K, Poitou C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts. 2016;9(3):158-173. doi:10.1159/000445061
  3. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity–assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709-757. doi:10.1210/jc.2016-2573
  4. Courbage S, Poitou C, Le Beyec-Le Bihan J, et al. Implication of heterozygous variants in genes of the leptin-melanocortin pathway in severe obesity. J Clin Endocrinol Metab. 2021;106(10):2991-3006. doi:10.1210/clinem/dgab404
  5. National Organization for Rare Disorders. POMC deficiency. NORD. Updated March 6, 2023. Accessed April 1, 2025. https://rarediseases.org/rare-diseases/pomc-deficiency
  6. Stijnen P, Ramos-Molina B, O'Rahilly S, Creemers JW. PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders. Endocr Rev. 2016;37(4):347-371. doi:10.1210/er.2015-1117
  7. Martín MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology. 2013;145(1):138-148. doi:10.1053/j.gastro.2013.03.048
  8. National Organization for Rare Disorders. PCSK1 deficiency. NORD. Updated February 22, 2023. Accessed April 1, 2025. https://rarediseases.org/rare-diseases/pcsk1-deficiency
  9. National Organization for Rare Disorders. LEPR deficiency. NORD. Updated February 21, 2023. Accessed April 1, 2025. https://rarediseases.org/rare-diseases/lepr-deficiency
  10. Cacciottolo TM, Henning E, Keogh JM, et al. Obesity due to steroid receptor coactivator-1 deficiency is associated with endocrine and metabolic abnormalities. J Clin Endocrinol Metab. 2022;107(6):e2532-e2544. doi:10.1210/clinem/dgac067
  11. Rui L. SH2B1 regulation of energy balance, body weight, and glucose metabolism. World J Diabetes. 2014 Aug 15;5(4):511-526. doi:10.4239/wjd.v5.i4.511
  12. Online Mendelian Inheritance in Man. Entries 609734, 600955, and 614963. Accessed March 31, 2025. https://www.omim.org
  13. National Institutes of Health. Autosomal dominant. MedlinePlus. Updated March 31, 2024. Accessed April 1, 2025. https://medlineplus.gov/ency/article/002049.htm
  14. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi:10.1038/gim.2015.30
  15. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18(7):1323-1331. doi:10.1093/hmg/ddp031
  16. Blaess S, Wachten D. The BBSome: a nexus controlling energy metabolism in the brain. J Clin Invest. 2021;131(8):e148903. doi:10.1172/JCI148903